Fuggle, Nicholas R. http://orcid.org/0000-0001-5463-2255
Beaudart, Charlotte
Bruyère, Olivier
Abrahamsen, Bo http://orcid.org/0000-0002-2730-6080
Al-Daghri, Nasser
Burlet, Nansa
Chandran, Manju
Rosa, Mario M. http://orcid.org/0000-0003-3158-2106
Cortet, Bernard
Demonceau, Céline
Dere, Willard
Halbout, Philippe
Hiligsmann, Mickaël
Kanis, John A.
Kaufman, Jean-Marc
Kurth, Andreas
Lamy, Olivier
Laslop, Andrea http://orcid.org/0009-0009-2707-3959
Maggi, Stefania
Matijevic, Radmila
McCloskey, Eugene http://orcid.org/0000-0003-0177-8140
Mobasheri, Ali http://orcid.org/0000-0001-6261-1286
Prieto Yerro, Maria C.
Radermecker, Régis P.
Sabico, Shaun http://orcid.org/0000-0002-5248-2350
Al-Saleh, Yousef
Silverman, Stuart
Veronese, Nicola http://orcid.org/0000-0002-9328-289X
Rizzoli, René http://orcid.org/0000-0002-1537-422X
Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Reginster, Jean-Yves
Harvey, Nicholas C. http://orcid.org/0000-0002-8194-2512
Article History
Accepted: 9 February 2024
First Online: 14 March 2024
Competing interests
: N.R.F. declares that he has received travel bursaries from Eli Lilly and Pfizer and speaker’s fees from Viatris outside the submitted work. B.A. declares that he has received speaker and/or consulting fees from UCB, Amgen, Kyowa-Kirin, and Pharmacosmos, and institutional research grants (with funds paid to the institution) from Novartis, Kyowa-Kirin and Pharmacosmos; he is a member of the Executive Committee of the European Calcified Tissue Society. O.B. declares that he has received consulting or lecture fees from Amgen, Aptissen, Biophytis, IBSA, Mylan, Novartis, Orifarm, Sanofi, UCB and Viatris outside the submitted work. B.C. declares that he has received personal fees, consultancy, lecture fees and/or honoraria from Alexion, Amgen, Expansience, Kyowa-Kirin, MSD, Novartis,Theramex, UCB, Viatris. M.C. declares that she has received honoraria from Kyowa Kirin and AMGEN for speaking and chairing engagements. W.D. declares that he is a shareholder and former employee of Amgen, and former board of director member of Radius Health. M.H. declares that he has received research grants (paid to his institution) from Radius Health and Amgen, consulting fees from UCB and lecture fees from Mylan Pharmaceuticals and IBSA (paid to his institution), outside this work. J.A.K. declares that he is a director of Osteoporosis Research Ltd, a member of the National Osteoporosis Guideline Group (UK), a member of the International Osteoporosis Foundation, and a member of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). J.M.K. declares that he is a board member (treasurer) of ESCEO. S.M. declares that she has received research grants and personal fees as an advisory board member and/or speaker fees from GSK, Pfizer, Merck, Sanofi, Takeda, Novavax, Viatris and Janssen outside the submitted work. R.M. declares that she has received personal fees from Amicus, ElPharma, Abela Pharm. A.K. declares that he has participated in advisory boards for Amgen, UCB, Agnovos, Alexion, Image Biopsy Lab, Theramex and speakers bureau for Amgen, Merit Medical, UCB, Agnovos, Alexion, Theramex, Stada; he is president of the Dachverband Osteologie e.V., Germany. M.M.R. declares that he is a Member of the Scientific Advice Working Party and Member of the Central Nervous System Working Party at the European Medicines Agency. S.Si. declares that he has received grant support from Amgen, consultancy fees from Amgen and Radius. N.V. declares that she has received personal fees from IBSA, Mylan, Viatris, Fidia, MSD, Bayer outside this work. R.R. declares that he has received fees as a speaker or consultant for Abiogen, Effryx, Nestlé, ObsEva and Theramex. C.C. declares that he has received personal fees from ABBH, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier and Takeda. J.Y.R. declares that he has received consulting fees or been on paid advisory boards for IBSA-Genevrier, Mylan, Radius Health, Pierre Fabre, Faes Pharma, Rejuvenate Biomed, Samumed, Teva, Theramex, Pfizer, Mithra Pharmaceuticals, received lecture fees when speaking at the invitation of the sponsor for IBSA-Genevrier, Mylan, Cniel, Dairy Research Council (DRC), Nutricia, Danone, Agnovos and received grant support from IBSA-Genevrier, Mylan, Cniel, Radius Health, TRB. N.C.H. declares that he has received personal fees, consultancy, lecture fees and/or honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, UCB, Kyowa Kirin, Servier, Shire, Consilient Healthcare, Theramex and Internis Pharma. The other authors declare no competing interests.
Free to read: This content has been made available to all.